Clinical trial
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
NCT00198458 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00198458 |
|---|---|
| Title | Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) |
| Official title | Clinical Evaluation of Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase, 150 USP Units/mL) Open Label, Normal Volunteer Study |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Drug Hypersensitivity |
| Intervention type | Drug |
| Interventions | Vitrase |
| Enrollment | 65 |
| Start date | Jul 1, 2004 |
| Primary completion | Jul 1, 2004 |
| Completion | Sep 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: